Bay Street News, November 13th, 2018

BURLINGTON, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider in cloud-based Web Content Management, […]

Year-Over-Year Revenue Growth of 27% to $16.4 Million and EPS Increase to $0.08 from $(0.03) in Q1 2018 Driven by […]

SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today provided […]

KP879 is being developed with serdexmethylphenidate, KemPharm’s prodrug of d-methylphenidate, to address a critical unmet need in the treatment of […]

DALLAS, Nov. 13, 2018 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced two […]

HOUSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical […]

First dose cohort fully enrolled First patient enrolled with relapsed/refractory Mantle Cell Lymphoma achieved Partial Response (PR) to lowest dose […]

Company on track to initiate Phase III trials in late November NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) — Eyenovia, […]

280 additional ATM locations to display the TD brand TORONTO, Nov. 13, 2018 (GLOBE NEWSWIRE) — Parkland Fuel Corporation (“Parkland”), […]

TORONTO and CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company […]